High level of IL-27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBV

Liver International

Volumn 34, Issue 2, 2014, Pages 266-273

  Zhang, Geng Lin ^a,b   Xie, Dong Ying ^a,b   Ye, Yi Nong ^a,b   Lin, Chao Shuang ^a,b   Zhang, Xiao Hong ^a,b   Zheng, Yu Bao ^a,b   Huang, Zhan Lian ^a,b   Peng, Liang ^a,b   Gao, Zhi Liang ^a,b  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hepatitis B virus; IL 27; Immunopathogenesis; Th17 cells

Indexed keywords

BILIRUBIN; GAMMA INTERFERON; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 27; INTERLEUKIN 4;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CD4+ T LYMPHOCYTE; CHRONIC HEPATITIS; CHRONIC LIVER FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN EXPRESSION; PROTHROMBIN TIME; TH1 CELL; TH17 CELL; TH2 CELL;

HEPATITIS B VIRUS; IL-27; IMMUNOPATHOGENESIS; TH17 CELLS;

BIOLOGICAL MARKERS; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-27; LIVER FAILURE, ACUTE; PILOT PROJECTS; PROTHROMBIN TIME; TH17 CELLS;

EID: 84891833299     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12268     Document Type: Article

References (28)

1. World Health Organization, Department of Communicable diseases surveillance and response. Hepatitis B. WHO Fact Sheets. Available at http://www.who.int. Accessed: 28 August 2007.
2. Ganem D, Prince AM. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004; 350: 1118-29.
3. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5: 215-29.
4. Lemmers A, Moreno C, Gustot T, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009; 49: 646-57.
5. Yasumi Y, Takikawa Y, Endo R, Suzuki K. Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol Res 2007; 37: 248-54.
6. Zhang JY, Zhang Z, Lin F, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51: 81-91.
7. + T cell lineage differentiation. Immunity 2009; 30: 646-55.
8. Yoshida H, Miyazaki Y. Regulation of immune responses by interleukin-27. Immunol Rev 2008; 226: 234-47.
9. Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002; 16: 779-90.
10. Wang SQ, Zhu CL, Zhang R, Liu L, Wu JG. Association of interleukin 27 expression and p28 gene polymorphism with chronic hepatitis B virus infection. J Toxicol Environ Health Sci 2009; 1: 028-33.
11. Zhu C, Zhang R, Liu L, et al. Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro. Clin Immunol 2009; 131: 92-7.
12. Kao JT, Lai HC, Tsai SM, et al. Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients. Liver Int 2012; 32: 928-36.
13. Chen Q, Ghilardi N, Wang H, et al. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 2000; 407: 916-20.
14. Pot C, Apetoh L, Awasthi A, Kuchroo VK. Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells. J Interferon Cytokine Res 2010; 30: 381-8.
15. Goldberg R, Wildbaum G, Zohar Y, Maor G, Karin N. Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27. J Immunol 2004; 173: 1171-8.
16. Batten M, Li J, Yi S, et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006; 7: 929-36.
17. Stumhofer JS, Laurence A, Wilson EH, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006; 7: 937-45.
18. Zhang GL, Xie DY, Lin BL, et al. Imbalance of Th17/Tregs axis occurs in remission stage of patients with HBV related acute-on-chronic liver failure. J Gastroenterol Hepatol 2013; 28: 513-21.
19. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-46.
20. Siebler J, Wirtz S, Frenzel C, et al. Cutting edge: a key pathogenic role of IL-27 in T cell- mediated hepatitis. J Immunol 2008; 180: 30-3.
21. Bender H, Wiesinger MY, Nordhoff C, et al. Interleukin-27 displays interferon-gamma-like functions in human hepatoma cells and hepatocytes. Hepatology 2009; 50: 585-91.
22. Schoenherr C, Weiskirchen R, Haan S. Interleukin-27 acts on hepatic stellate cells and induces signal transducer and activator of transcription 1-dependent responses. Cell Commun Signal 2010; 8: 19.
23. Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol 2007; 85: 16-23.
24. Jiang R, Feng X, Guo Y, et al. T helper cells in patients with chronic hepatitis B virus infection. Chin Med J (Engl) 2002; 115: 422-4.
25. Fitzgerald DC, Ciric B, Touil T, et al. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 2007; 179: 3268-75.
26. Yoshizaki A, Yanaba K, Iwata Y, et al. Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation. Ann Rheum Dis 2011; 70: 194-200.
27. El-behi M, Ciric B, Yu S, et al. Differential effect of IL-27 on developing versus committed Th17 cells. J Immunol 2009; 183: 4957-67.
28. Pène J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008; 180: 7423-30.